Background and Purpose-ANRIL encodes a long antisense noncoding RNA in the INK4 locus. Although ANRIL has been proven to be associated with coronary heart disease, its roles in stroke are inconsistent, and sparse data are available regarding hemorrhagic stroke. Methods-A Chinese case-control study was conducted, comprising 1657 cases (724 atherothrombosis, 466 lacunar infarction, and 462 hemorrhagic strokes) and 1664 controls. Stroke patients were prospectively followed-up for a median of 4.5 (range, 0.1-6.0) years. Expression of ANRIL transcripts was examined in 42 human atherosclerotic plaques. Results-After adjustment for vascular risk factors and correction for multiple comparisons, subjects carrying the GG genotype of rs10757278 had 1.47-fold (95% CI, 1.11-1.89; Pϭ0.05) and 1.60-fold (95% CI, 1.16 -2.15; Pϭ0.04) increased risk for atherothrombotic and hemorrhagic strokes, respectively. During the follow-up, 317 recurrent strokes and 301 deaths from all causes were documented. Subjects carrying rs10757278GG had higher risk for stroke recurrence (relative risk [RR],1.56; 95% CI,1.15-2.12; Pϭ0.005) and cardiovascular mortality (RR, 2.0; 95% CI, 1.26 -3.18; Pϭ0.003), respectively. Rs10757274 was also associated with stroke risk and recurrence. Family history of stroke further increased the stroke risk by 2.37-fold (95% CI, 1.38 -4.06; Pϭ0.01) and recurrent stroke risk by 2.45-fold (95% CI, 1.56 -3.86; PϽ0.0001) respectively, when compared with those carrying none of G-alleles and without family history. Finally, rs10757278 was associated with differential expression of the ANRIL transcripts. Conclusions-Our findings indicated that the ANRIL may serve as a novel genetic marker for the risk of atherothrombotic and hemorrhagic stroke and their recurrence. (Stroke. 2012;43:14-21.)
S
troke is a major cause of death and disability worldwide and in China. Survivors are often disabled, require long-term care, and are at high risk of recurrence. Among subtypes of stroke, hemorrhagic stroke accounts for 20% to 40% in the Chinese population; in contrast, the majority (80 -90%) of strokes are cerebral infarctions in most western populations. 1 The reasons for high risk of stroke, especially hemorrhagic stroke, among the Chinese, remain unknown. The contribution of genetic risk to stroke is still not completely understood.
It is generally accepted that genetic variants on chromosome 9p21.3 are associated with the risk of coronary artery disease, [2] [3] [4] but its roles in stroke are inconsistent. [5] [6] [7] [8] [9] [10] [11] [12] A recent meta-analysis 13 showed that the association of 9p21.3 with stroke is only confined to the subtype of large-vessel strokes. However, a recent genome-wide association study showed that the 9p21.3 region is also implicated in risk for intracranial aneurysm, in which atherosclerosis is not thought to play a major role. 14 Therefore, additional studies are needed to determine the mechanisms by which the 9p21.3 region affects vascular risk, especially given that the pathogenic features for ischemic and hemorrhagic stroke are known to differ.
ANRIL, a newly annotated gene encoding a long antisense noncoding RNA in the INK4 locus, 15 overlaps with the 9p21.3 risk interval and may have distinct regulatory roles in the expression of adjacent protein coding genes, including methylthioadenosine phosphorylase (MTAP) and 2 cyclindependent kinase inhibitors, CDKN2A (encoding p16 INK4a and p14 ARF ) and CDKN2B (encoding p15 INK4b ). The ANRIL may be involved in the atherosclerotic process such as in thrombogenesis, vascular remodeling and/or repair, and plaque stability. 16 To date, the studies regarding the effect of 9p21.3 on expression of ANRIL transcripts are inconsistent [17] [18] [19] [20] [21] ; particularly, most data are from circulating blood cells. 17, 18 The relation between 9p21.3 and gene expression in the atherosclerotic plaque region remains to be established.
To clarify the role of 9p21.3 in ischemic and hemorrhagic stroke, we investigated the association of genetic variants at the ANRIL locus on 9p21.3 with susceptibility to stroke in a large case-control study in the Chinese Han population. We further assessed the relationship between variants and stroke recurrence by prospectively following up patients with stroke for a median of 4.5 years. We also analyzed the effects of 9p21 on expression levels of ANRIL transcripts and the nearby gene clusters in human atherosclerotic plaques.
Methods

Stroke Sample Population
The Multicenter Chinese Stroke Study comprised 2000 consecutive stroke patients (age 35-74 years) and age-, sex-, and resident-areamatched control subjects, which have been described previously. 22 The criteria of diagnosis and recruitment were given in details in Supplemental Materials (http://stroke.ahajournals.org). Before data assessment, we excluded 679 subjects because of lack of definite diagnosis (24 cases), absence of plasma (76 cases, 93 control subjects), and insufficient DNA (243 cases, 243 control subjects). No significant differences were found in clinical characteristics between included and excluded subjects. Finally, 1657 cases and 1664 control subjects were eligible for genetic association analysis.
The study was approved by the local ethics committees of collaborating hospitals. All participants reported to be Han nationality and provided written informed consent.
Follow-Up and Outcome Assessment
Stroke patients in this cohort were followed up for a 2-year period until May 31, 2006 , by a standard questionnaire and by telephone contact by physician investigators. The end points were recurrent strokes and deaths. Recurrent stroke was defined using the following criteria: clinical evidence of the sudden onset of a new focal neurological deficit with no apparent cause other than that of vascular origin occurring at any time after the index stroke; or, there was clinical evidence of the sudden onset of an exacerbation of a previous focal neurological deficit with no apparent cause other than that of vascular origin occurring Ͼ21 days after the index stroke. 23 All reports of stroke events were confirmed by a local neurologist, based on direct review of patient medical records and brain imaging.
For patients who were not hospitalized and were evaluated by primary care physicians in the community, the recurrent stroke type was categorized as undetermined stroke or possible stroke. An undetermined stroke was a stroke in which a patient had not undergone computed tomography scanning within 28 days of the onset of symptoms. A possible stroke was defined as any episode of neurological disturbance that was suggestive of stroke, but there was insufficient information available to categorize the case definitely as "stroke" or "not stroke" according to the World Health Organization definition; or, it was insufficiently clear whether the duration of focal neurological disturbance was Ͼ24 or Ͻ24 hours.
Deaths were reported by family members, work associates, and/or obtained from death certificates and medical records. They were coded according to International Classification of Diseases-9, and codes 390 to 459 were classified as cardiovascular deaths.
Genotyping of Variants at the ANRIL Locus on Chromosome 9p21.3
Four variants (rs10757274, rs2383206, rs2383207, and rs10757278) at the ANRIL locus were selected for genotyping because they are associated with coronary heart disease, [2] [3] [4] and this has subsequently been replicated in Asian populations. 10, 24 Two previously reported susceptibility variants, rs1004638 10 and rs1333049, 4 were not included in the study, because rs1004638 is in a complete linkage disequilibrium with rs2383207 (␥ 2 ϭ1.0); this is so also between rs1333049 and rs10757278 (␥ 2 ϭ1.0). The tested variants flank a 58-kb noncoding risk interval on 9p21.3 from 22 062 301 to 22 120 389 (National Center for Biotechnology Information build 36.1; Supplemental Figure S1 ). Genomic DNA was isolated from the white blood cell buffy coat. The variants were genotyped by a ligase detection reaction method. Genotyping was performed by laboratory personnel blinded to case-control status and the outcome assessment. The primer and probe sequences are summarized in Supplemental Table S1 .
RNA Isolation and Quantitative Real-Time Polymerase Chain Reaction Analysis
SYBR green-based quantitative real-time polymerase chain reaction was used to examine changes in expression levels of MTAP, p16 INK4a , p14 ARF , p15 INK4b , and ANRIL transcripts in RNAs prepared from the human atherosclerotic plaques (nϭ42). The utilization of human vascular tissues was approved by the ethics committee of Fu Wai Hospital. Quantitative real-time polymerase chain reaction assays were performed in duplicates with DNA Engine Opticon 2 Real-Time PCR Detection (Bio-Rad). Primers and amplification reactions were provided in Supplemental Table S2 . The relative mRNA expression levels were normalized to the housekeeping gene GAPDH and presented as log 2 -transormed expression (⌬⌬Ct).
Statistical Analysis
Normal distribution of data was examined by the KolmogorovSmirnov normality test. The 2 test was used to examine the Hardy-Weinberg equilibrium for each variant and to compare the distribution of allele and genotype frequencies between cases and control subjects. Logistic regression models were performed to estimate ORs and 95% CIs for the association between genotypes and stroke. Multivariate analyses were adjusted for age, sex, body mass index, fasting triglycerides, total cholesterol, high-density lipoprotein cholesterol, fasting blood glucose, blood pressure, smoking status (never, past, current), alcohol intake (current drinker, yes/no), history of hypertension (yes/no), and diabetes (yes/no). The genetic associations with stroke risk were corrected for multiple comparisons (for the 4 tested variants and the 3 stroke subtypes) by the Simes method, a modified Bonferroni procedure. 25 The significance of multiplicative interactions between the variants and family history of stroke was determined by the likelihood ratio test. The linkage disequilibrium between tested variants was calculated using Haploview software 4.2, and R 2 was used to indicate the strength of linkage disequilibrium. Haplotype analysis was conducted based on the Stochastic-EM algorithm using the THESIAS program. 26 Person-years of follow-up started from the date of diagnosis of the first-ever stroke until the date of a first recurrence of stroke, death, or the end of follow-up (May 31, 2006) . For those who were lost-to-follow-up (80/1657 cases [4. 8%]), it ended with the date last known to be alive. Cox proportional-hazards models were used to examine the association between variants and stroke recurrence or mortality after adjustment for age, sex, other covariates, stroke subtypes, neurological deficit, and antihypertensive medication. We plotted the receiver operating characteristic curves for prediction models with and without family history of stroke and risk variants, and compared the area under an receiver operating characteristic curve (AUC) to evaluate the discriminatory ability of the model, including family history and risk variants.
Multiple linear regression models were used to examine the correlation between variants and mRNA expression of MTAP, p16 INK4a , p14 ARF , p15 INK4b , and ANRIL transcripts in human atherosclerotic lesions. Differences in expression levels across the geno-types were compared by ANOVA, a Tukey test was performed as post hoc test, and the probability value was corrected for multiple comparisons (for the 4 tested variants and the 5 transcripts) by the Simes method. 25 All probability values were 2-sided, and PϽ0.05 was considered significant. Analyses were performed with SPSS software, version 13.0 (SPSS Inc).
Results
Clinical Characteristics of Study Participants
In this study, age, presented as meanϮSD, was 60.4Ϯ9.2 years in cases and 59.8Ϯ8.2 years in controls, and men accounted for 63.7% of cases and 58.6% of controls (Supplemental Table S3 ). As expected, stroke patients had a higher prevalence of conventional vascular risk factors, including smoking, alcohol intake, family history of stroke, and history of hypertension and diabetes; they also had higher levels of blood glucose and triglycerides; and lower level of high-density lipoprotein cholesterol.
During a median of 4.5 (range, 0.1-6.0) years of follow-up for 1657 patients with stroke, 80 patients (4.8%) were lost because of emigration. No substantial differences were found in genotype frequencies and baseline characteristics between the follow-up and lost-to-follow-up subjects (Supplemental Table S4 ). A total of 317 recurrent strokes and 301 deaths from all causes (170 deaths from stroke or coronary heart disease and 131 deaths from other causes) were documented. In this study, 85.5% of 317 recurrent strokes were in patients admitted to a hospital for evaluation and had a computed tomography or magnetic resonance imaging within 10 days of symptom onset; 14.5% of patients were not hospitalized and were evaluated by primary care physicians in the community. Of the recurrent stroke types, ischemic stroke occurred in 74.5%, intracerebral hemorrhage in 11%, undetermined strokes in 10%, and possible strokes in 4.5%, respectively.
Association Between Variants at the ANRIL Locus and Stroke
The frequencies of 4 tested variants did not deviate significantly from the Hardy-Weinberg equilibrium in cases and control subjects (all PϾ0.05). Before implementation of this study, we performed a statistical power analysis using the Quanto program 27 to verify whether the recruited samples could provide adequate power to identify the genetic association. The present study had Ͼ90% power to detect an association with ORs of Ն1.20 at the nominal type I error rate Ͻ0.05 for variants with allelic frequency Ͼ0. 30 .
In an allelic association analysis, the G-alleles of rs10757274 and rs10757278 were associated with increased risk of stroke and its recurrence (Supplemental Table S5A and S5B). After adjustment for age, sex, history of coronary heart disease, and other vascular risk factors, subjects with the GG genotype of rs10757274 and rs10757278 had 1.41-fold (95% CI, 1.15-1.71; Pϭ0.001) and 1.35-fold (95% CI, 1.10 -1.64; Pϭ0.003) increased risk of stroke compared with the respective AA-genotype carriers. Stroke subtype analysis showed that the G-allele of rs10757274 and rs10757278 was associated with increased susceptibility to atherothrombotic and hemorrhagic stroke, but not to lacunar stroke. After correction for multiple comparisons, the associations remained statistically significant (Table) . Because the observed association between 9p21.3 and stroke could be biased because of the association with coronary heart disease, we also performed sensitivity analyses by excluding those subjects with history of heart diseases, and the results were not substantially changed (Supplemental Table S6 ). The effects of rs2383206 and rs2383207 on stroke risk did not reach statistical significance after correction for multiple comparisons.
After adjustment for vascular risk factors, subjects carrying the GG genotype of s10757274 had increased risks for stroke recurrence (relative risk [RR], 1.66; 95% CI, 1.23-2.24; Pϭ0.001) and cardiovascular mortality (RR, 1.98; 95% CI, 1.29 -3.04; Pϭ0.002) compared with the AA genotype carriers. Rs10757278 was also associated with the risk of stroke recurrence and cardiovascular mortality (Figure 1 ). The Kaplan-Meier curves associated with rs10757274 and rs10757278 were given in Supplemental Figure S2 , showing the higher cumulative rate of stroke recurrence or cardiovascular mortality in those carrying the at-risk G-allele. As antihypertensive therapy might affect the association, we performed a stratified analysis by antihypertensive therapy, and the results were not significantly altered.
Combined Effects of the ANRIL Variants and Family History of Stroke
Family history of stroke was significantly associated with the risk of stroke recurrence (Supplemental Table S7 ); therefore, we further assessed whether the risk variants rs10757274 and rs10757278 could add information to stroke risk for individuals with family history of stroke. After adjustment for conventional vascular risk factors and correction for multiple comparisons, we found that subjects who carried 4 copies of the at-risk G-allele and also had family history of stroke had a 2.37-fold (95% CI, 1.38 -4.06; corrected Pϭ0.01) increased risk of stroke and 2.45-fold (95% CI, 1.56 -3.86; corrected PϽ0.0001) increased risk of recurrent strokes during the follow-up, respectively, compared with those without the at-risk G-allele and without stroke family history (Figure 2) . The P for interaction was Ͻ0.0001 for stroke and 0.07 for recurrent strokes, respectively.
The risk variants rs10757274 and rs10757278 alone had an inadequate discriminatory ability with the AUC of 0.55 (95% CI, 0.53-0.71) for stroke risk and 0.59 (95% CI, 0.56 -0.63) for stroke recurrence, respectively (Supplemental Figure S3) . The AUC for conventional vascular risk factors was 0.73 (95% CI, 0.72-0.75) for stroke, and adding the risk variants only marginally, but significantly, increased this to 0.76 (95% CI, 0.75-0.78; Pϭ0.02); when further combined with stroke family history, the AUC was significantly increased to 0.78 (95% CI, 0.76 -0.80; Pϭ0.01). Similar trends were found for stroke recurrence when risk variants were incorporated into conventional risk factors among persons with family history of stroke.
In addition, because the 2 risk variants were in a tight linkage disequilibrium (␥ 2 ϭ0.93) in this studied population, a haplotype analysis using the 2 variants was performed to assess the haplotype effect on the risk of stroke and its recurrence in relation to family history of stroke; this showed that associations between the risk GG-haplotype and stroke or its recurrence were stronger in those who had family history of stroke than in the AA-haplotype carriers who had no family history (Supplemental Table S8A and S8B).
Relationship Between Variants and Expression of ANRIL and the Neighboring Genes in Atherosclerotic Plaques
To elucidate whether expression of ANRIL and the neighboring genes were affected by variants on 9p21.3, we systematically analyzed the mRNA levels of MTAP, p16 INK4a , p14 ARF , p15 INK4b , and ANRIL transcripts in 42 human carotid atherosclerotic plaques. Our data revealed that the expression levels of MTAP, and ANRIL short transcripts DQ485454 and EU741058 significantly decreased in carriers of the rs10757278GG genotype compared with the AA genotype; however, the same risk genotype was associated with increased expression of p16 INK4a and ANRIL long transcript NR_003529 (Figure 3 ). These effects remained significant after correction for multiple comparisons. No significant associations were found between rs10757274, rs2383206, and rs2383207 and expression of these genes (Supplemental Table S9 ).
In addition, we tested whether there was a correlation of MTAP, p16 INK4a , p14 ARF , and p15 INK4b with ANRIL transcripts expression. We found that EU741058 and DQ485454 were positively correlated with MTAP expression (␥ϭ0.75, PϽ0.001; ␥ϭ0.54, Pϭ0.001, respectively), whereas NR_003529 was positively correlated with p16
INK4a expression (␥ϭ0.84, PϽ0.0001; Supplemental Figure S4 ).
Discussion
In this large Chinese stroke study, we confirmed the association between variants at the ANRIL locus on 9p21.3 2 test, cases vs control subjects. ‡Multivariate unconditional logistic regression analysis adjusting for age, sex, body mass index, triglycerides, total cholesterol, high-density lipoprotein cholesterol, blood glucose, blood pressure, smoking status, alcohol intake, diabetes, family history of stroke, history of hypertension, and coronary heart disease.
§Obtained by the Simes' procedure, a modified Bonferroni correction for multiple comparisons.
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and atherothrombotic stroke. We also provided novel evidence that 9p21.3 contributes to the risk of hemorrhagic stroke. To our knowledge, this is the first time showing that 9p21.3 independently predicts the risk of stroke recurrence and cardiovascular mortality during long-term follow-up, independent of traditional vascular risk factors. Additional expression analyses in human atherosclerotic plaques showed that variants on 9p21.3 region resulted in changes in the expressions of the ANRIL transcripts.
In addition, we found that family history of stroke further increased the stroke risk to 2.37-fold in subjects carrying 4 copies of G-allele of rs10757274 and rs10757278, and also increased the risk of stroke recurrence (2.45-fold). Thus, a combination of the risk variants on 9p21.3 with family stroke history could help to predict an individual's risk of stroke.
The strengths of the study are 2-fold. First, the large number of stroke patients allowed us to examine the genetic impact of 9p21.3 in different subtypes. In previous studies, the number of hemorrhagic strokes was too small to allow for any conclusion as to whether 9p21.3 has any effect on this particular subtype of stroke. The present study provided novel evidence that genetic variants at the ANRIL increase susceptibility to hemorrhagic stroke, adding to recent studies in patients with intracranial aneurysm. 14 Hemorrhagic stroke results from the spontaneous rupture and bleeding of vessels because of microaneurysms from hypertension, cerebral amyloid angiopathy in elderly, or unidentified risk ) of stroke recurrence and mortality according to variants at the ANRIL in the prospective stroke population. RRs (95% CI) were obtained with multivariate Cox regression models by adjusting for age, sex, and conventional risk factors, including body mass index, smoking, alcohol intake, blood glucose, total cholesterol, high-density lipoprotein cholesterol, triglyceride, blood pressure, history of hypertension and diabetes, location of clinic centers, stroke subtypes, neurological deficit, and antihypertensive medication.
factors. 28 These findings together indicate a key role of the ANRIL in vascular biology.
The second strength of the study included its prospective design, high follow-up rate (94.6%), and long-term follow-up period. This is the first study to investigate whether 9p21.3 is associated with the outcome after stroke, and our findings showed that the ANRIL play an important role in the risk of stroke recurrence and cardiovascular mortality. Stroke is a major disorder in China; therefore, the population-attributable fraction may be high even for genetic variants conferring a modestly relative risk, given its high prevalence.
Several studies have examined the role of genetic variants on 9p21.3 in ischemic stroke and produced inconsistent results. Of these, 2 small studies found no association, 6, 29 whereas a recent meta-analysis showed that this risk is confined to the large-artery stroke subtype. 13 Our findings verified the association of 2 variants rs10757274 and rs10757278 with susceptibility to atherothrombotic stroke, but not to lacunar infarction. The study in a small Chinese Han sample by Hu et al 8 showed that rs2383206 has a significant association with large-vessel strokes. Here, our data showed that the effect of rs2383206, which is in 1 haplotype block with rs10757274 and rs10757278, did not reach statistical significance related to the risk of atherothrombotic stroke after correction for multiple comparisons. The specific variants within the ANRIL may represent either the same signal or different signals that give similar effects.
Our findings together with previous studies suggest that variants at the ANRIL may exert more general effects on arterial wall function, such as vascular remodeling and/or repair, that is common to coronary heart disease, large-vessel stroke, and hemorrhagic stroke. ANRIL is expressed in cells that play a critical role in atherogenesis, such as macrophages, vascular smooth muscle cells, and endothelial cells. Targeted deletion of the orthologous ANRIL risk interval in mice can reduce expression of CDKN2A and CDKN2B in the heart and lead to excessive proliferation of vascular cells. 30 In addition, long antisense noncoding RNAs may play a key role in epigenetic mechanisms. A recent study showed that 9p21 variants affect the binding of a specific transcriptional factor STAT1, lead to changes in chromatin architecture, and then impair the interferon-␥-mediated inflammatory response that has been linked with angiogenesis and atherosclerosis. 31 Thus, the combined effect of genetics and microenvironment may result in vessel dysfunction in particular vascular regions.
The effect of 9p21.3 on expression of the ANRIL transcripts has not yet to be clearly determined. The studies of Figure 1 . B, Relative risks of the stroke recurrence risk, with multivariate Cox regression models by adjusting for the same covariates as in Figure 1 .
Holdt et al 16, 19 showed that variants on 9p21.3 are associated with increased expression of NR_003529 and EU741058 in human atherosclerotic plaques. Jarinova et al 18 reported an association with decreased NR_003529, but increased DQ485454 and EU741058, in whole blood from healthy individuals. Recent work from Burd et al 32 demonstrated decreased expression of EU741058 (called ANRIL1-2 in that study) associated with rs10757278GG genotype in human primary peripheral blood T lymphocytes. In this study, we provided additional evidence that risk variants on 9p21.3 affect the expression of ANRIL transcripts and neighboring protein-coding genes, suggesting that ANRIL may play a regulatory role in p16 INK4a and MTAP expression related to the at-risk-allele of rs10757278. More evidence will be helpful for clarifying the mechanism by which 9p21.3 affects vascular risk.
Our study had potential limitations. Not all variants at the ANRIL were assessed in this study, so complete sequencing will be necessary for systematic identification of potentially causative mutations. We did not validate our findings in a second, independent, case-control study, so more replication studies in various stroke populations are needed. In this study, stroke patients were followed up by telephone contact by physician investigators rather than by face-to-face interview. However, all reports of stroke recurrences were confirmed by a local neurologist, based on direct review of patient medical records and brain imaging. Another limitation is the lack of information on statin usage. Recent evidence shows that statins reduce stroke recurrence and may improve prognosis poststroke. 33 However, based on a national survey on serum cholesterol levels in China, awareness, treatment, and control rates of hypercholesterolemia in the Chinese population were extremely low 34 ; therefore, it seems not likely that our results were affected meaningfully.
Conclusions
In summary, our data of this large Chinese stroke population provided novel evidence that variants at the ANRIL locus on chromosome 9p21.3 are not only associated with susceptibility to atherothrombotic and hemorrhagic strokes, but also independently predict the risk of stroke recurrence and cardiovascular mortality, particularly among persons with a family history of stroke. This was strengthened by the finding that variants on 9p21.3 influence the expression of ANRIL transcripts in human atherosclerotic plaques. Although the current risk variants on 9p21.3 do not provide strong predictive value at a population level, but explain a small amount of the heritability of stroke, this suggests that genetic information may have considerable clinical utility in improving the risk prediction of stroke among those high-risk individuals. Additional data are required to confirm this.
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Supplemental Methods
Stroke Sample Population
In this Multicenter Chinese Stroke Study, 2,000 consecutive stroke patients (age 35 to 74 years) and age-, gender-, and resident area-matched control subjects were recruited from November 2000 to November 2001 from seven clinical centers in northern China [1, 2] . Stroke was defined according to the World Health Organization (WHO) definition as "rapidly developing clinical signs of focal (or global) disturbance of cerebral function lasting more than 24 hours (unless interrupted by surgery or death) with no apparent cause other than of vascular origin." [3] . The definition excludes cases of primary cerebral tumor, cerebral metastasis, subdural hematoma, postseizure palsy, brain trauma, and TIA. The diagnosis of stroke was confirmed by strict neurological examination, computed tomography (CT), or magnetic resonance imaging (MRI). Three subtypes of stroke were included: cerebral thrombosis (atherothrombosis), lacunar infarction (lacunar), and intracerebral hemorrhage (ICH). Other types of stroke (embolic stroke and subarachnoid hemorrhage) and systemic diseases (collagenosis, inflammation, liver, or renal diseases) were exclusion criteria.
Atherothrombotic stroke was defined as an occlusion or >50% stenosis of a major brain artery or branch cortical artery on duplex sonography or angiography and corresponding to the clinical features of cerebral cortical, brain stem or cerebellar dysfunction; no definite cardiac source of embolism; cortical, cerebellar, brain stem or subcortical infarct was ≥15 mm in diameter on CT or MRI.
Lacunar infarction was diagnosed if the patient had one of the characteristic clinical lacunar syndromes, and CT or MRI showed either normal or a deep focal infarction in brainstem or subcortical region with a diameter of <15 mm.
Intracerebral hemorrhage (ICH) was diagnosed if a CT scan demonstrated an area of hyperdensity within the brain parenchyma with or without extension into the ventricles or subarachnoid space or, for scans performed beyond 1 week, an area of attenuation with ring enhancement after injection of contrast.
Controls were selected from inpatients (21.5%) with minor illness from the departments of ophthalmology, gastroenterology, otorhinolaryngology, and orthopedics and from community-based inhabitants (78.5%) free of neurological diseases, following the same exclusion criteria as case subjects. In each local community, both men and women 35 to 74 years of age in the range of selection were grouped by age (5-year range for each group), and the control subject was randomly selected from the corresponding group.
Biochemical Variable Determination and Clinical Data Collection
Blood samples were collected after a 12-hour overnight fast. Plasma and cell buffy coat were separated by centrifugation, and kept at -70°C. Biochemical variables, including blood glucose, total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C), were assayed by using an automatic analyzer (Hitachi 7060, Tokyo, Japan). A complete medical history and vascular risk factors were recorded on hospital admission: smoking, alcohol intake, body mass index (BMI), systolic and diastolic blood pressure, family history of stroke, and history of hypertension and diabetes. Stroke severity was measured using Chinese Scale of Clinical Neurological Deficit of Stroke Patients, which was adapted from NIHSS (National Institutes of Health Stroke Scale) [4] .
Genotyping of Variants at the ANRIL Locus on Chromosome 9p21.3
The variants were genotyped by a ligase detection reaction (LDR) by the Shanghai Biowing Applied Biotechnology Co., Ltd. The primer and probe sequences and PCR and LDR product lengths of the variants are summarized in Supplemental Material (Table S1) TTTTTTTTTTTTTTTTTTTTTTTTTTTTTATCTAGTGAATTTCAATTATGTCT  111  rs10757274_G  TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTATCTAGTGAATTTCAATTATGTCC  114  rs2383206_modify  P-ACTACAATAACATTTCTAAGGAAAATTTTTTTTTTTT-FAM  rs2383206_A  TTTTTTTTTTTTTTCAGGATTCAGGCCATCTTGCAAAT  75  rs2383206_G  TTTTTTTTTTTTTTTTCAGGATTCAGGCCATCTTGCAAAC  78  rs2383207_modify  P-GAAGGGATCCGAACAGGAGTAAAAATTTTTTTTTTTTTTTTTTT-FAM  rs2383207_A  TTTTTTTTTTTTTTTTTTAAATAGTAAATAATCATGCTTAGC  87  rs2383207_G  TTTTTTTTTTTTTTTTTTTTTAAATAGTAAATAATCATGCTTAGCC  90  rs10757278_modify  P-TACCGGAATGACCACACCCTGACTTTTTTTTTTTTTTTTTTTTTTTTTT-FAM  rs10757278_A  TTTTTTTTTTTTTTTTTTTTTTTTTTCTGTCTTGATTCTGCATCGCTGCT  99  rs10757278_G  TTTTTTTTTTTTTTTTTTTTTTTTTTTTTCTGTCTTGATTCTGCATCGCTGCC  102 PCR, polymerase chain reaction; LDR, ligase detection reaction. *The copies of DQ485454 were determined by subtraction of NR_003529 copies from Σ NR_003529+DQ485454. 0.31 *P value, the follow-up vs the lost-to-follow-up subjects: the two-sample t-test was used for comparison of continuous variables, the chi-square test for categorical variables and genotype frequencies, and the Mann-Whitney U test for triglycerides. ICH denotes hemorrhagic stroke. *Crude ORs (95%CI) were determined by  2 test, cases vs control subjects. †Adjusted ORs (95%CI) and adjusted P value were obtained with multivariate unconditional logistic regression analysis by adjusting for age, gender, BMI, triglycerides, total cholesterol, HDL-C, blood glucose, blood pressure, smoking, alcohol intake, diabetes, history of hypertension and coronary heart disease. †crude ORs (95%CI) were determined by 2 test, cases vs control subjects. ‡Adjusted ORs (95%CI) and adjusted P value were obtained with multivariate unconditional logistic regression analysis by adjusting for age, gender, BMI, triglycerides, total cholesterol, HDL-C, blood glucose, blood pressure, smoking, alcohol intake, diabetes, and history of hypertension. §Corrected P value was obtained by the Simes' procedure, a modified Bonferroni correction for multiple comparisons. †Model I: adjustment for age, gender, and conventional risk factors, including body mass index, triglycerides, total cholesterol, HDL-C, blood glucose, blood pressure, smoking, alcohol intake, diabetes, history of hypertension and coronary heart disease.
‡Model II: adjustment for the same covariates as model I, plus family history of stroke. Model B includes conventional risk factors (including age, gender, BMI, triglycerides, total cholesterol, HDL-C, blood glucose, blood pressure, smoking, alcohol intake, diabetes, and history of hypertension);
